Biogen Inc. 8-K Filing: Key Developments Revealed on May 1, 2025
Based on the provided section of the financial report, here are the key insights and information extracted:
- Entity Identification:
- Company Name: Biogen Inc.
- CIK Number: 0000875045
- SEC Central Index Key (CIK): Identifies the company in SEC filings.
- Filing Type:
- Form Type: 8-K
- Filing Date: May 1, 2025
- The 8-K form is used to report major events that shareholders should know about.
- Company Information:
- Incorporation State: Delaware (DE)
- IRS Employer Identification Number: 33-0112644
- Address: 225 Binney Street, Cambridge, MA 02142
- Phone Number: 617-679-2000
- Securities Information:
- Type of Security: Common Stock
- Par Value: $0.0005
- Ticker Symbol: BIIB
- Exchange: NASDAQ
- Reporting Period:
- Start Date: May 1, 2025
- End Date: May 1, 2025
- The report pertains to a specific event or condition occurring on the same date.
Insights:
- This filing indicates that Biogen Inc. has reported a significant event or development to the SEC on May 1, 2025, as per the requirements of the 8-K form.
- The inclusion of the address and contact information provides stakeholders with the necessary details to reach the company for further inquiries.
- The par value of the common stock suggests a low nominal value, which is common for many publicly traded companies.
This information can be crucial for investors, analysts, and stakeholders monitoring Biogen Inc.'s activities and financial health.